You are here
Presentation in today's Extraordinary General Meeting
8 Feb 2008: In today`s Extraordinary General Meeting CEO Mårten Wigstøl will give the shareholders a presentation of the Company`s current situation. The presentation is attached.
Contact:
CEO Mårten Wigstøl
Phone: +47 911 65775
About NorDiag ASA:
NorDiag is a biotechnology company developing, manufacturing and marketing of automated solutions, instruments and tests, for diagnostic of cancer and infectious diseases. The Company`s first product in cancer diagnosis is Genefec TM for diagnosis of colorectal cancer. NorDiag has also launched a product for diagnostic of sexual transmitted infectious. In addition, the company has other applications for early diagnosis of cancer under development, as well as applications for other infectious diseases in the product pipeline. NorDiag is listed on Oslo Stock Exchange with the ticker NORD. www.nordiag.com.